Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Social distancing

- PMLiVE

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

First patient is likely to be treated later in the year due to pandemic

- PMLiVE

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

Monthly meeting held remotely for the first time due to COVID-19 pandemic

- PMLiVE

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Fallout from pandemic continues to affect business in myriad ways

- PMLiVE

Novartis forms coronavirus alliance with life sciences companies

Partnership will accelerate research with aid of Gates Foundation

- PMLiVE

BMS suspends new clinical trials as COVID-19 cases rise in US

Existing sites can continue to recruit new subjects

- PMLiVE

UK-Senegal partners plan to validate ten-minute COVID-19 diagnostic

Rapid test kit will aim to curb virus' spread across Africa

- PMLiVE

NHS to set up hospital in ExCeL Centre as coronavirus cases grow

Over half a million people have also volunteered with the health service

- PMLiVE

UPDATED: Gilead drops remdesivir’s orphan drug designation

Decision comes amid intense public criticism of the regulatory status

Roche Basel Switzerland

FDA approves Roche’s Actemra COVID-19 trial

Plans to initiate trial in early April

- PMLiVE

Lilly halts most clinical trials as coronavirus disruption continues

Will continue ongoing trials for patients who are already enrolled

- PMLiVE

FDA green lights rapid coronavirus diagnostic test

Test can diagnose positive cases in approximately 45 minutes

- PMLiVE

Gilead halts individual requests for COVID-19 hopeful remdesivir

Will now focus on expanded access programmes and backlog

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links